India, Nov. 30 -- What are the key strategies lined up for Illumina in 2026, for India? How much revenue growth is expected for FY 25-26?
We are making steady progress on our strategy to drive customer-centric innovation, operational excellence, and revenue growth. Our transformation remains focused on customers and execution excellence to drive the company forward.
To further boost inclusive innovation, we are now expanding beyond metros - bringing training, partnerships, and technology to Tier 2 and Tier 3 cities, empowering local healthcare providers and improving access to genomic solutions.
In India, we see strong momentum in digital health and diagnostics, with growing demand for clinical Next-Generation Sequencing (NGS) and Non-...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.